Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting ...

Kennedy jnr announced a crackdown on mRNA vaccine technology and research to develop it, following months of pressure from ...

That kind of shot was first used during the Covid-19 pandemic, but the health secretary has been sharply critical of the ...

PFE posts strong Q2 results with earnings up 30% and revenues up 10% year over year, fueled by rising oncology sales and cost ...

Pharmaceutical major recorded a revenue jump to $14.65 billion, exceeding the market expectations. The company also raised ...

The trade war between China and the US is entering the next round and reaching a new peak. The Middle Kingdom is restricting ...

Pfizer beats Q2 2025 estimates, raises EPS guidance, boasts a 7%+ dividend yield, yet faces patent and pricing risks. See why ...

Health Secretary Robert F. Kennedy Jr. has canceled nearly $500 million of grants and contracts for developing mRNA vaccines, ...

Now, it’s worth noting Stock Advisor's total average return is 1,019% — a market-crushing outperformance compared to 178% for the S&P 500. Don’t miss out on the latest top 10 list, available when you ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

The company posted strong second-quarter results and reaffirmed its guidance for 2025. Enbridge posted EBITDA of C$4.6 ...